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© 2011 The Japan Society of Histochemistry and The TRK-fused gene (TFG in human, Tfg in rat) was originally identified in human papillary
thyroid cancer as a chimeric form of the NTRK1 gene. It has been reported that the gene
product (TFG) plays a role in regulating phosphotyrosine-specific phosphatase-1 activity.
However, no information regarding the localization of Tfg in rat tissues is available. In this
study, we investigated the expression of Tfg mRNA in normal rat tissues using reverse
transcription-polymerase chain reaction (RT-PCR). We also produced an antibody against
Tfg gene products and examined the localization of TFG in the rat brain and retina. The RT-
PCR experiments demonstrated that two types of Tfg mRNA were expressed in rat tissues:
the conventional form of Tfg ( cTfg) and a novel variant form, retinal Tfg (rTfg). RT-PCR
analyses demonstrated that cTfg was ubiquitously expressed in rat tissues, while rTfg was
predominantly expressed in the brain and retina. Western blot analysis demonstrated two
bands with molecular weights of about 30 kDa and 50 kDa in the rat brain. Immunohisto-
chemistry indicated that TFG proteins were predominantly expressed by neurons in the brain.
In the rat retina, intense TFG-immunoreactivity was detected in the layer of rods and cones
and the outer plexiform layer.
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I. Introduction
The TRK-fused gene (TFG in human, Tfg in rat) was
first identified in human papillary thyroid carcinoma as a
fusion partner of the NTRK1 gene, which encodes a
tyrosine kinase receptor for nerve growth factor [11, 12].
As a result of chromosomal rearrangements, TFG is fused
to the 3' end of the NTRK1 gene, generating the TRK-T3
oncogene [5]. In addition to thyroid cancer, TFG gene is
expressed as a fusion partner of various cancer oncogenes,
such as anaplastic large cell lymphoma [8] and myxoid
chondrosarcoma [9].
The TFG gene is highly conserved among mammals
such as human, pig, and mouse, and also in C. elegans [16].
The TFG protein (TFG) contains a coiled-coil sequence in
the N-terminal region, an N-glycosylation site, phosphory-
lation sites for casein kinase 2 and protein kinase C (PKC),
and SH2- and SH3-binding motifs [15]. These structures are
important for oncogenic activation in carcinoma; however,
the function of TFG protein is unclear. In 2005, Roccato et
al. reported that TFG protein interacts with and negatively
regulates SH2 domain-containing phosphotyrosine-specific
phosphatase-1 (SHP-1) [21]. SHP-1 is expressed in the
hematopoietic system [19, 22], epithelial cells [18] and the
nervous system [10, 14]. Therefore, TFG protein may play
an important role in these tissues by regulating SHP-1. In
addition, the analogue of TFG gene in C. elegans, tfg-1,
suppresses apoptosis and is essential for normal cell size [3].
Recently, we cloned a novel variant of Tfg from a rat
retinal cDNA library and named it retinal Tfg (rTfg). While
Northern blot analyses have demonstrated that TFG is widely
expressed in various fetal and adult tissues of human [5]
and mouse [16], there is no information about the localizationMaebayashi et al. 16
of  Tfg gene and TFG protein in the rat. In this study,
therefore, we examined the expression patterns of Tfg
mRNAs in normal rat tissues using quantitative reverse
transcription-polymerase chain reaction (RT-PCR), and used
immunohistochemistry to localize TFG proteins in rat brain
and retina using an antibody against the common parts of
the conventional and variant forms of TFG proteins.
II. Materials and Methods
Animals
This study was performed in accordance with the PHS
Policy on Humane Care and Use of Laboratory Animals,
the NIH Guide for the Care and Use of Laboratory Animals
(NIH publication No. 85-23, revised 1985) and the Animal
Welfare Act (7 U.S.C. et seq.). The animal use protocol was
approved by the Institutional Animal Care and Use Com-
mittee of Shiga University of Medical Science. Ten Wistar
rats weighing 200–300 g were used in this study. The animals
were housed under a 12:12 hr light-dark schedule and had
food and water available ad libitum.
For the production of antisera against the common
region of TFG proteins, three Japanese white rabbits (Kiwa
Lab., Wakayama, Japan), weighing 2.0–2.5 kg, were used.
The animals were injected every 2 weeks with the fusion
protein (200 μg/rabbit) emulsified with Freund’s adjuvant
(Life Technologies Inc.). Blood samples were collected 4
days after every booster injection. The specificity of the
antiserum was examined by Western blot analysis and
immunoabsorption tests as described below.
Immunoscreening of cDNA library from rat retina
The rTfg cDNA was cloned from a rat retinal cDNA
library using an antiserum against deltorphin [1, 2]. A rat
L Zap cDNA library (Clontech Laboratories, Mountain
View, CA, USA) was used. The final library containing
1×106 plaques was screened with the deltorphin antiserum.
Clones detected by this screening were applied to a second
screening, and screening was repeated until a monoclonal
colony was obtained.
The inserted cDNA of a phage from each colony was
amplified by polymerase chain reaction (PCR) using
AmpliTaq Gold and universal primers. The amplified cDNA
was subcloned into a pCR2 vector using a TA cloning kit
(Invitrogen Corp., Carlsbad, CA, USA), and the cDNA
sequence was determined using an ABI 3100 DNA
sequencer (Applied Biosystems, Foster City, CA, USA).
Tissue preparations
Ten male Wistar rats (two for mRNA analysis, two
for Western blots and six for immunohistochemistry)
weighing 200–300 g, were used. Rats were purchased from
Clea Japan (Osaka, Japan). Tissue preparation was per-
formed essentially as reported before [7, 13, 23]. In brief,
under pentobarbital anesthesia (80 mg/kg), four animals
were perfused via the ascending aorta with 10 mM phosphate
buffer containing 0.9% NaCl (PBS; pH 7.4) to remove blood.
Two rats were used for each of Western blot analysis and
RT-PCR experiments. For immunohistochemistry, the other
six rats were transcardially perfused with 10 mM PBS
followed by an ice-cold fixative of 0.1 M phosphate buffer
(PB; pH 7.4) with 4% formaldehyde (FA). The brain and
eyes were removed from each rat and postfixed for 24 hr
in 0.1 M PB containing 4% FA at 4°C. The tissues were
then immersed for at least 48 hr in 0.1 M PB containing
15% sucrose and 0.1% sodium azide for cryoprotection. The
tissues were cut into 20 μm thick sections using a cryostat.
Some sections were mounted onto gelatin-chrome-coated
glass slides and other sections were used in a free-floating
state.
RT-PCR experiments
Total RNA was isolated from the retina, brain, liver,
kidney, heart and lung using the acid guanidium thiocyanate-
phenol method [4]. Prior to reverse transcription, the total
RNA was incubated for 1 hr with 10 units of RNase-free
DNase I (Amersham Biosciences Corp.) and 20 units of
recombinant RNase inhibitor (Wako Pure Chemicals, Osaka,
Japan) at 37°C, to eliminate any trace DNA contamination.
RNA (5 μg) was then reverse transcribed for first strand
cDNA synthesis using 80 units of SuperScript II (Gibco
BRL, Gaithersburg, MD, USA) and 500 pmol of oligo
dT12–18 (Amersham Biosciences Corp) as the primers.
In addition, β-actin mRNA was amplified to assess
the variability of mRNA contents. The primers for β-actin
PCR were designed to encompass different exons, and
were expected to yield a 266 base pair (bp) PCR fragment.
The reaction mixture for PCR consisted of 2 ng/μl of the
template cDNA, 0.8 μM of each of the primers, 0.2 mM of
each of four deoxynucleotide triphosphates and 2.0 U Taq
polymerase (AmpliTaq Gold, PerkinElmer Japan Co, Tokyo,
Japan) dissolved in 1×PCR buffer containing 1.5 mM MgCl2.
After heat activation for 10 min at 95°C, the sample was
amplified using the following profile of thermal cycling: (1)
denaturation at 95°C for 30 sec; (2) annealing at 56°C for
30 sec; and (3) extension at 72°C for 60 sec. We performed
the PCR for 28–30 cycles. The PCR products obtained were
electrophoresed on a 1–3% agarose gel and stained with
ethidium bromide. The nucleotide sequences of the PCR
products were determined using an ABI 3100 DNA
sequencer (Applied Biosystems).
The quantification of rTfg mRNA in various tissues
was analyzed by real-time PCR using a Light Cycler (Roche
Applied Science, Mannheim, Germany). The sense primer
was 5'-AGATTGAAGGTCAGATGTAC-3' and the anti-
sense primer was 5'-GGAAGTTGGTTGTTGGCCAT-3'. β-
actin was used as an internal control to normalize the data.
The reaction mixture consisted of 1 X LC-FastStart mixture
(Roche Applied Science, Mannheim, Germany), 4 mM
MgCl2, 0.5 μM primers and 10 ng/μl cDNA. Cycling
conditions involved an initial 10 min incubation at 95°C
followed by 1–50 cycles of denaturation at 95°C for 15 sec;
annealing at 56°C for 8 sec for rTfg, and at 58°C for 5 sec
for β-actin; and extension at 72°C for 15 sec. The expressionTFG Proteins in the Rat Brain and Retina 17
levels of the rTfg mRNA in the tissues were normalized to
that of β-actin mRNA.
Production of antibody against TFG gene products
Antisera were raised using a synthetic peptide corre-
sponding to the common region of TFG protein and its
variant as an antigen (SGPPSAPTEDRSGTP: amino acid
number 194–208, Accession number BC078947 on Gen-
Bank). The peptide was conjugated to bovine serum albumin
(BSA) with glutaraldehyde. Three Japanese white rabbits
(Kiwa Lab., Wakayama, Japan) received an initial subcuta-
neous injection of 200 μg of the hapten antigen mixed with
equal volume of Freund’s complete adjuvant. The animals
received subsequent injections of the hapten antigen mixed
with incomplete adjuvant every two weeks. The antisera
were collected 4–7 days after each boost. The specificity
of the antisera was examined by Western blot and an
immunoabsorption test.
Purification of antibody specific to TFG gene products using 
affinity chromatography
An antiserum was purified by affinity chromatography
using CNBr activated sepharose gel bounded with the
antigenic peptide (SGPPSAPTEDRSGT). One ml of the
antiserum was applied to the affinity chromatograph. After
washing the unbound protein with 10 mM PBS (pH 7.4,
unbound fraction), the binding IgG was eluted by 0.1 M
glycine HCl (pH 2.3). The purified IgG was neutralized with
1 M Tris HCl (pH 8.0). The eluted fraction was dialyzed
with 10 mM PBS, and then stored in 50% glycerol/PBS.
The immunoactivity was confirmed by ELISA assay and an
immunospot test. The purification was done by Medical &
Biological Laboratories, Co. Ltd. (Ina, Japan).
Immunospot test
The antigenic peptide (SGPPSAPTEDRSGT) was
purchased from Medical & Biological Laboratories, Co. Ltd.
(Ina, Japan). Small drops (~1 μl) of the peptide were spotted
on the nitrocellulose membrane at doses of 1000, 250, 63,
16, 4 and 1 ng/μl. After drying in air, the membrane was
incubated with 2% gelatin in 25 mM Tris HCl-buffered
saline (pH 7.5) containing 0.1% Tween 20 (TBST) to block
non-specific protein binding (Sigma). The membrane was
incubated for 1 hr with the pre-purified antibody (1:10,000),
the unbound fraction (0.5 μg/ml) or the purified antibody
(0.5 μg/ml) in TBST.  After washing with TBST, the mem-
brane was incubated for 1 hr with a peroxidase-coupled anti-
rabbit IgG Fab’ fragment (Histofine; Nichirei Corp., Tokyo,
Japan; diluted 1:10). Peroxidase labeling was detected
with 0.02% 3,3'-diaminobenzidine in 50 mM Tris-HCl
buffer (pH 7.6) containing 0.3% nickel ammonium sulfate.
Western blot analysis
The brains were homogenized in 5 volumes of ice-
cold 500 mM Tris-HCl (pH 7.4) containing 1% Triton-
X100, 1 mM EDTA, 1 mM EGTA, 1 μg/ml pepstatin and
Complete Mini protease inhibitor cocktail tablets (Roche
Diagnostics, Mannheim, Germany; 1 tablet/10 ml). The
homogenates were centrifuged at 12,000 g for 20 min at
4°C. The supernatants were collected as a crude protein
fraction. Approximately 50 μg of the crude protein and pre-
stained Precision Protein Standards (Bio-Rad Laboratories,
Hercules, CA, USA) were electrophoresed on a 5–20%
sodium dodecyl sulfate-polyacrylamide gel (Wako Pure
Chemicals, Osaka, Japan) under reducing conditions and
then transferred to a polyvinyliden difluoride membrane
(Immobilon-P, Millipore Japan, Osaka, Japan). The mem-
brane was incubated with 5% skim milk in 25 mM TBS for
1 hr at room temperature (RT), and further incubated with
the purified TFG antibody (0.5 μg/ml) in 25 mM TBS
containing 1% skim milk overnight at 4°C. After washing
with 25 mM TBST, the membrane was reacted for 1 hr with
a peroxidase-coupled anti-rabbit IgG (Jackson Laboratories;
diluted 1:20,000) at RT. Chemiluminescence signals were
obtained by using West Pico Substrate (Pierce Biotechnol-
ogy, Rockford, IL).
Immunohistochemistry
Immunohistochemical staining for TFG was performed
as previously described [15, 20, 23]. In brief, the sections
were kept at 4°C for at least 4 days in 0.1 M PBS containing
0.3% Triton X-100 (PBST; pH 7.4) before staining. Sections
were incubated for 20 min with PBST containing 0.3% H2O2
at room temperature to eliminate endogenous peroxidase.
After washing with PBST, sections were incubated for 30
min with PBST containing 2% BSA to inhibit non-specific
protein binding. The sections were incubated in sequence
with: the rabbit anti-TFG antibody (1:20,000) or the purified
TFG antibody (0.1 μg/ml) at 4°C for 2–3 days; biotinylated
anti-rabbit IgG (1:1,000; Vector Laboratories, Burlingame,
CA, USA) for 1 hr at RT; and avidin-biotin-peroxidase
complex (1:4,000; Vector Laboratories) for 1 hr at RT. PBST
containing 0.2% BSA was used to dilute the antibodies and
PBST was used to wash the sections between each step. A
purple color was developed with 0.02% 3,3'-diaminobenzi-
dine and 0.3% nickel ammonium sulfate in 50 mM Tris-
HCl buffer (pH 7.6). The free-floating sections were
mounted on gelatin-chrome-coated glass slides and air-dried.
In addition, some rat retinal sections were used for
immunofluorescent histochemistry [17]. The sections were
incubated with the purified TFG antibody (0.1 μg/ml) at
4°C for 2–3 days. After washing with PBST, the sections
were incubated in the dark for 2 hr with Alexa Fluor
647 conjugated anti-rabbit IgG (1:500; Molecular Probes,
Eugene, OR, USA) at RT. After three rinses with PBST
sections were mounted on silane-coated glass slides and
examined under a confocal microscope (Nikon C1si,
TE2000-E, Nikon, Tokyo, Japan).
For the immunoabsorption test, the purified antibody
was preincubated with the TFG peptide (100 μg/ml) over-
night at 4°C, and the sections were stained as described
above. All staining was abolished following pre-incubation
of the antibody with the TFG peptide.Maebayashi et al. 18
Fig. 1. Comparison of cTfg (upper) and rTfg (lower) cDNA structures. The rTfg contains additional one exon (exon 7 indicated by red).
Fig. 2. Amino acid sequence of cTFG and rTFG protein. A putative coiled-coil domain is underlined and italicized. N-glycosylation sites are
underlined. Putative phosphorylation sites for protein kinase C and casein kinase 2 are indicated by dashed underlining. Myristylation sites are
indicated by double underlining. SH2-binding sites are indicated by wavy line. SH3-binding sites are indicated in bold. Note that three SH3-
binding sites of cTFG protein are lost in rTFG protein.TFG Proteins in the Rat Brain and Retina 19
III. Results
Cloning and sequencing of a variant of the Tfg gene
We  cloned  a  variant  of  the  Tfg  gene  from  rat
retinal tissue that contains an open reading frame of 837
bp, and encodes 282 amino acids plus a stop codon, a
polyadenylation-signal and a poly A tail. The sequence had
98% similarity to cTfg mRNA, and we named it retinal Tfg
(rTfg). According to the rat genome, the rTfg contained one
additional exon (exon 7, red in Fig. 1) in comparison to the
cTfg. The cTfg encodes a 42.9 kDa protein consisting of
396 amino acids, while rTfg encodes a 31.0 kDa protein
consisting of 282 amino acids (Fig. 1).
Figure 2 shows a comparison of amino acid sequences
between rat cTFG and rTFG proteins. Both proteins are rich
in glutamine (Q). Eleven amino acids in the C-terminus of
the rTGF protein are different from those of the cTFG
protein. A putative coiled-coil domain (underlined, italicized
characters), myristylation sites (double underline), SH2-
binding site (wave line), and phosphorylation sites for PKC
and casein kinase 2 (dashed underline) are preserved in the
rTFG protein. However, three SH3-binding sites (bold),
three myristylation site (double underline) and one glyco-
sylation site (single underline) are lost in rTFG protein.
Expression of cTfg and rTfg mRNAs in adult rat tissues
Figures 3A, B and C show the results of RT-PCR
experiments using primer pairs to amplify both cTfg and
rTFfg, rTfg and β-actin transcripts, respectively. The cTfg
mRNA was detected in all tissues examined (arrow in
Fig. 3A), while the rTfg mRNA (arrowhead in Fig. 3A) was
only detected in the brain (lane 1 in Fig. 3A) and retina
(lane 6 in Fig. 3A). When we used the primer pair specific
to rTfg, the expression level of rTfg mRNA was found to
be relatively high in the brain (lane 1 in Fig. 3B) and retina
(lane 6 in Fig. 3B). β-actin mRNA was evenly expressed in
all tissues examined (Fig. 3C). The real-time PCR demon-
strated high expression levels of rTfg mRNA in the brain,
and this was normalized to 100% (Fig. 3D). The expression
level of rTfg mRNA in the retina was 24.7% of that in the
Fig. 3. RT-PCR (A, B, C) and real time-PCR (D) analyses of Tfg mRNAs and proteins in the rat retina. A: RT-PCR experiment using a primer
set for the common region of cTfg and rTfg. A strong band of 170 bp (arrowhead) and a faint band of 211 bp (arrow) correspond well to the
sizes of cTfg and rTfg, respectively. B: RT-PCR experiment using a primer set specific for rTfg. A single band of 426 bp is seen. C: RT-PCR
experiment using a primer set specific for β-actin. β-actin mRNA was evenly expressed in all tissues examined. D: Real-time PCR demon-
strated high expression levels of rTfg mRNA in the brain, and this was normalized to 100%. M indicates a marker. 1; brain, 2; heart, 3; lung, 4;
colon, 5; liver, 6; retina.
Fig. 4. Immunospot test (A) of antigenic peptide detected by the
antiserum (1, diluted at 1:10,000), unbounded fraction (2, diluted at
0.5  μg/ml) and purified antibody (3, diluted at 0.5 μg/ml), and
Western blot analysis (B) of rat brain homogenates probed with the
purified antibody (diluted at 0.5 μg/ml). A: Antibodies pre- (1) and
post- (3) purification using affinity chromatography of antigenic
peptide detect the peptide at a concentration of 25 ng/μl. Unbound
fraction cannot detect the antigen (2). B: The purified antibody
detected two bands with molecular weights of approximately 30
kDa (arrowhead) and 50 kDa (arrow).Maebayashi et al. 20
Fig. 5. Immunohistochemical localization of TFG proteins in the midbrain (A, B, C), cerebellum (D), and the pons (E, F, G) using the antibody
against the common region of cTFG and rTFG proteins. A–C: In the midbrain, intensely stained neurons were seen in the mesencephalic
nucleus of the trigeminal nerve (B) and dorsal raphe nucleus (C). as; the aqueductus cerebri. D: In the cerebellum, Purkinje cells with dendritic
processes were clearly stained. E–G: In the pons, neurons in the lateral vestibular nucleus (F) and cochlear nucleus were strongly positive for
TFG. Bars=1 mm (A, E); 100 μm (B, C, D, F and G).TFG Proteins in the Rat Brain and Retina 21
brain, while in all other tissues, the mRNA level of rTfg
was less than 20% of that in the brain.
Characterization of the antiserum against TFG proteins
The characterization of the antiserum against TFG
proteins was examined by an immunospot test, Western
blots and an immunoabsorption test. Figure 4A shows the
immunospot test of the antigenic peptide probed with the
antiserum (lane 1, diluted at 1:10,000), unbounded fraction
(lane 2, diluted at 1 μg/ml) and purified antibody (lane 3,
diluted at 1 μg/ml). The antiserum (lane 1) and affinity-
purified antibody (lane 3) detected the peptide at an amount
of 250 ng/μl and 63 ng/μl, respectively. Unbound fraction
failed to detect the antigen (lane 2). Figure 4B demonstrates
the result of Western blot analysis of adult rat brain probed
with the purified antibody. The antibody detected an intense
band of about 50 kDa (arrow) and a weak band of about 30
kDa (arrowhead) in the brain homogenate.
Localization of TFG proteins in adult rat brain and retina
In the brain, TFG immunostaining was localized to
neuronal structures including neuronal somata and proximal
processes (Fig. 5). Positive neurons were mainly distributed
in the hindbrain area. In the midbrain (Fig. 5A–C), intensely
stained neurons were observed in the mesencephalic nucleus
of trigeminal nerve (Fig. 5B) and the raphe dorsalis
(Fig. 5C). In the cerebellum, Purkinje cells with dendrites
were clearly stained (Fig. 5D). In the pons (Fig. 5E),
intensely stained neurons were seen in the lateral vestibular
nucleus (boxed area F in Fig. 5E) and cochlear nucleus
(boxed area G in Fig. 5E). In the lateral vestibular nucleus,
large neurons with proximal processes were positive for
TFG (Fig. 5F).
In the retina, TFG was present in the layer of rod and
cone cells (RCL) and the outer plexiform layer (OPL)
(Fig. 6), and the outer nuclear layer (ONL) was also weakly
stained, as demonstrated by immunohistochemical staining
(Fig. 6B) and immunofluorescent histochemistry (Fig. 6C
and 6D) using the purified antibody against the common
region of cTFG and rTFG. Pre-incubation of the antibody
with a TFG peptide confirmed all staining observed is
specific for TFG proteins (Fig. 6E).
IV. Discussion
Structure of cTFG and rTFG
In the present study, we investigated the expression
and localization of a splice variant of Tfg cDNA, which we
have named retinal Tfg (rTfg), in the adult rat brain and
retina. The amino acid sequence showed that rTFG protein
is a glutamine (Q)-rich protein, and compared with the
conventional cTfg cDNA, rTfg cDNA carries the insertion
of one exon (exon 7 in Fig. 1). Thus, rTfg mRNA is generated
by alternative splicing. Since the amino acid sequence of
the rTFG exon 7 contains a stop codon, rTfg mRNA encodes
a 31.0 kDa protein, meaning that the molecular weight of
rTFG protein is smaller than that of the cTFG protein (42.9
kDa). The rTFG protein preserves the regions that are
predicted to be important for transformation and oncoprotein
activation, including the coiled-coil domain [5, 6] and SH2-
binding motif [20], suggesting that rTFG may have a similar
role to cTFG protein. However, three SH3-binding sites
(bold), three myristylation site (double underline) and one
glycosylation site (single underline) are lost in rTFG protein.
Therefore, it cannot be ruled out that cTFG and rTFG have
different functions. For example, a previous study suggested
that the SH3-binding motifs are not related to oncoprotein
activation [20]. In order to clarify the issue, further studies
will be needed.
The expression patterns of cTfg and rTfg
The RT-PCR experiments demonstrated the ubiquitous
expression of cTfg mRNA, and confirms previous reports
[5, 16]. In contrast, rTfg mRNA was preferentially expressed
Fig. 6. Immunohistochemical staining using the purified antibody against the common region of cTFG and rTFG proteins. A: Hematoxylin and
eosin staining shows the layers of the rat retina. RCL, layer of rod and cone cells; ONL, outer nuclear layer; OPL, outer plexiform layer; INL,
inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer. B: Immunohistochemistry shows intense TFG staining in the RCL
and OPL and weak staining in the ONL. C: Immunofluorescent histochemistry shows TFG-immunopositivity in the RCL, ONL and OPL.
D: Merged photographs of the immunofluorescent histochemistry and bright field photographs. E: Staining is abolished following preincubation
of the antibody with the TFG peptide (100 μg/ml). Bar=50 μm.Maebayashi et al. 22
in the brain and less characteristically in the retina. Western
blot analysis of brain homogenates using the purifed
antibody against the common region of cTFG and rTFG
proteins showed two bands with molecular weights of about
30 kDa and 50 kD. The results thus indicated that both types
of  Tfg are expressed in the brain and retina at both the
mRNA and protein level. The intensity of 50 kDa band was
much stronger than that of 30 kDa band. The results suggest
that the cTFG is the main form of TFG proteins in the brain.
Interestingly, the molecular weight of 50 kDa is
larger than predicted based upon the amino acid sequences
of the cTFG protein, suggesting that cTFG protein has
undergone post-translational modifications such as glycosy-
lation and myristylation, because they have glycosylation
and myristylation sites (Fig. 2).
Localization of TFG proteins in the brain and retina
Immunohistochemistry using the antibody against the
common region of cTFG and rTFG proteins indicated that
TFG proteins are localized to neurons in specific brain
regions. Interestingly, positive neurons are richly distributed
in the hindbrain area. The results suggest that TFG proteins
may play a role in specific neuronal functions. To clarify
this, we are now trying to map the distribution of TFG-
positive neurons in the rat brain.
In the retina, TFG staining patterns differed across the
cell layers. In particular, TFG immunostaining was observed
in the RCL and the OPL. The ONL was also weakly stained.
In these three layers, there are cell bodies and processes of
rod and cone cells. Therefore, TFG protein may play an
important role of rod and cone cells. Further studies will be
needed to clarify this issue.
Conclusion
We cloned a TFG-like gene cDNA from a rat retinal
cDNA library, and named it retinal Tfg (rTfg). Compared
with the structure of conventional cTfg, rTfg contains one
additional exon (exon 7) and preserves the regions that are
important for oncogene activation. RT-PCR and Western
blot analyses demonstrated that both cTfg and rTfg are
expressed at the mRNA and protein levels in the brain and
retina of adult rats. Immunohistochemistry using the purified
antibody against the common region of the cTFG and
rTFG proteins revealed that TFG proteins are localized to
some neurons in specific brain regions. In the retina, TFG
immunostaining was observed in the RCL and OPL, and
the ONL was also weakly stained. The purified antibody
should be a useful tool for further investigating TFG proteins.
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